Find Grants for Native American & Tribal Governments
Find out if you qualify for verified grants for Native American & Tribal Governments. Discover your eligibility and key funding details for Native American & Tribal Governments from major foundations and government agencies.
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-063
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.242
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-153
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.395
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-325
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.866, 93.867, 93.286, 93.395, 93.394
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-145
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-036
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.866, 93.242
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-175
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393, 93.395, 93.394
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-24-311
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.395, 93.396
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-24-321
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.866
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-227
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-221
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.396, 93.273
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-24-306
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.393, 93.395, 93.396, 93.394
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Deadline: January 6, 2028
Opportunity Number: PAS-25-205
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.839, 93.847, 93.866
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
Deadline: September 28, 2026
Opportunity Number: RFA-NS-25-021
Agency: National Institutes of Health
Open Date: November 5, 2024
Close Date: September 28, 2026
Status: Posted
CFDA Numbers: 93.866, 93.867, 93.242, 93.213, 93.865, 93.173, 93.853, 93.286, 93.273, 93.279
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Deadline: September 28, 2026
Opportunity Number: RFA-NS-25-022
Agency: National Institutes of Health
Open Date: November 5, 2024
Close Date: September 28, 2026
Status: Posted
CFDA Numbers: 93.866, 93.867, 93.286, 93.279, 93.865, 93.853, 93.273, 93.173, 93.213, 93.242
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Deadline: October 25, 2027
Opportunity Number: PAR-25-104
Agency: National Institutes of Health
Open Date: November 5, 2024
Close Date: October 25, 2027
Status: Posted
CFDA Numbers: 93.399
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Deadline: October 25, 2027
Opportunity Number: PAR-25-103
Agency: National Institutes of Health
Open Date: November 5, 2024
Close Date: October 25, 2027
Status: Posted
CFDA Numbers: 93.399
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Deadline: October 20, 2027
Opportunity Number: PAR-25-225
Agency: National Institutes of Health
Open Date: November 4, 2024
Close Date: October 20, 2027
Status: Posted
CFDA Numbers: 93.853
Human-Environment and Geographical Sciences Program
Deadline: January 16, 2026
Opportunity Number: 25-507
Agency: U.S. National Science Foundation
Open Date: November 2, 2024
Close Date: January 16, 2026
Status: Posted
CFDA Numbers: 47.075
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: October 16, 2026
Opportunity Number: PAR-25-077
Agency: National Institutes of Health
Open Date: November 1, 2024
Close Date: October 16, 2026
Status: Posted
CFDA Numbers: 93.853, 93.855
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-143
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.279, 93.242, 93.273, 93.989, 93.307, 93.172, 93.866, 93.399, 93.846, 93.361, 93.173, 93.121, 93.113, 93.855, 93.865, 93.213, 93.853, 93.310
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-207
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Deadline: June 2, 2027
Opportunity Number: PAR-25-210
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: June 2, 2027
Status: Posted
CFDA Numbers: 93.866, 93.313, 93.393, 93.213, 93.121
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
Deadline: June 2, 2027
Opportunity Number: PAR-25-211
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: June 2, 2027
Status: Posted
CFDA Numbers: 93.393, 93.121, 93.213, 93.313, 93.866
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-206
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
Deadline: January 27, 2027
Opportunity Number: PAR-24-268
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: January 27, 2027
Status: Posted
CFDA Numbers: 93.121, 93.242, 93.866, 93.273, 93.859, 93.853, 93.213, 93.867, 93.279, 93.310, 93.846
